D
Sell
7/10/2023Upgraded
PROCEPT BioRobotics Corporation (PRCT) was upgraded to D- from E+ on 7/10/2023 due to an increase in the volatility index and valuation index.
E
Sell
3/14/2023Downgrade
PROCEPT BioRobotics Corporation (PRCT) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index, solvency index and growth index. The quick ratio declined from 9.58 to 6.72, operating cash flow declined 26.81% from -$19.85M to -$25.17M, and earnings per share declined from -$0.51 to -$0.6314.
D
Sell
2/9/2023Upgraded
PROCEPT BioRobotics Corporation (PRCT) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
PROCEPT BioRobotics Corporation (PRCT) was downgraded to E+ from D on 2/8/2023 due to a decline in the solvency index, growth index and valuation index. The quick ratio declined from 15.06 to 9.58, EBIT declined 23.66% from -$17.88M to -$22.11M, and earnings per share declined from -$0.4328 to -$0.51.
D
Sell
5/4/2022Upgraded
PROCEPT BioRobotics Corporation (PRCT) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell
5/1/2022Downgrade
PROCEPT BioRobotics Corporation (PRCT) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
PROCEPT BioRobotics Corporation (PRCT) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and volatility index.
E
Sell
4/20/2022Downgrade
PROCEPT BioRobotics Corporation (PRCT) was downgraded to E+ from D on 4/20/2022 due to a major decline in the efficiency index, volatility index and total return index. Net income declined 30.1% from -$14.1M to -$18.35M, and total capital declined 4.84% from $339.12M to $322.69M.
D
Sell
12/8/2021None
PROCEPT BioRobotics Corporation (PRCT) was downgraded to D from U on 12/08/2021.
